Literature DB >> 21631987

Molecular aspects of chronic radiation enteritis.

Yanfei Zhu1, Jing Zhou, Guoqing Tao.   

Abstract

PURPOSE: Chronic radiation enteritis (CRE) is one of the most feared complications of abdominal or pelvic radiation therapy and the treatment of CRE is difficult and often controversial. Recent progress in molecular biology has shed some light on the pathogenesis of CRE, which is characterized by fibrosis. The purpose of this article is to summarize the current state of knowledge of molecular aspects of radiation induced intestinal fibrosis and to discuss potential therapeutic targets.
METHODS: A review of the up-to-date published literature involving the possible molecular cascades in radiation-induced intestinal fibrosis and prospective targets for CRE were performed using the Pub-Med search engine.
RESULTS: Fibrosis development is correlated with transforming growth factor β1 (TGF-β1) and its downstream effector Smad3, which stimulates fibrogenic downstream mediators, such as connective tissue growth factor (CTGF). Ras homologue (Rho) and Rho-associated kinase (ROCK) signaling pathway have been shown to play important roles in the development of CRE. The inhibition of these pathways ameliorated radiation-induced intestinal fibrosis in vitro and in animal studies; however, the relationship between the Smad3 and Rho signaling pathways has not been elucidated.
CONCLUSIONS: Rho/ROCK and TGF-β1/Smad3 signaling pathways have been shown to play a key role in intestinal fibrogenesis, which might provide with effective possibilities for clinical intervention. Understanding the cooperation between Smad3 and Rho, may therefore be critical to our overall understanding of fibrosis development and maintenance of CRE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631987     DOI: 10.25011/cim.v34i3.15183

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  7 in total

Review 1.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

Review 2.  Radiation enteritis.

Authors:  Ali H Harb; Carla Abou Fadel; Ala I Sharara
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 3.  Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.

Authors:  Carlos Rodrigo Camara-Lemarroy
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice.

Authors:  Jinmeng Zhang; Xinjia He; Xinya Bai; Yang Sun; Peng Jiang; Xiang Wang; Wei Li; Yuliang Zhang
Journal:  J Radiat Res       Date:  2020-09-08       Impact factor: 2.724

5.  Herb-Partitioned Moxibustion Improves Crohn's Disease-Associated Intestinal Fibrosis by Suppressing the RhoA/ROCK1/MLC Pathway.

Authors:  Min Zhao; Zhijun Weng; Yan Huang; Handan Zheng; Dong Han; Jiacheng Shen; Rong Huang; Huirong Liu; Luyi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-17       Impact factor: 2.629

6.  Musashi expression in intestinal stem cells attenuates radiation-induced decline in intestinal permeability and survival in Drosophila.

Authors:  Amit Sharma; Kazutaka Akagi; Blaine Pattavina; Kenneth A Wilson; Christopher Nelson; Mark Watson; Elie Maksoud; Ayano Harata; Mauricio Ortega; Rachel B Brem; Pankaj Kapahi
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

7.  Effects of UCMSCs Delivered through Different Transplantation Approaches on Acute Radiation Enteritis in Rats.

Authors:  Jun Li; Yinghong Jiang; Hua Yu; Lejiang Liu; Qiang Wang; Hongpin Ju; Xuemei Zhang; Wenqi Wang; Xudong Yin; Qiong Wu; Jianzhong Xiao; Jianrong Miao; Xiao Ye; Tianyu Li; Hui Tian; Wei Xue
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.